BRAFv-raf murine sarcoma viral oncogene homolog B
Autism Reports / Total Reports
7 / 20Rare Variants / Common Variants
50 / 0Aliases
BRAF, B-RAF1, BRAF1, NS7, RAFB1Associated Syndromes
Cardiofaciocutaneous syndrome, Cardiofaciocutaneous syndrome, DD, epilepsy/seizurChromosome Band
7q34Associated Disorders
ID, ASDGenetic Category
Rare Single Gene Mutation, SyndromicRelevance to Autism
De novo missense variants in the BRAF gene have been identified in ASD probands from the Autism Sequencing Consortium (De Rubeis et al., 2014) and the SPARK cohort (Wang et al., 2020). Single-molecular molecular inversion probe (smMIP) sequencing of 125 genes in over 16,000 cases with neurodevelopmental disorders and comparison of the mutation burden to non-psychiatric controls from ExAC in Wang et al., 2020 identified BRAF as a gene showing a significant burden of ultra-rare (MAF < 0.01%) missense variants with CADD scores equal to or greater than 30 (Mis30 variants) with a false discovery rate (FDR) less than 5%; a total of 11 Mis30 variants in BRAF from 14 individuals were used in this analysis, with 5 of these individuals coming from cohorts with a primary diagnosis of ASD. Patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found in two reports to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
Molecular Function
This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome (CFC) [MIM:115150], a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung.
External Links
SFARI Genomic Platforms
Reports related to BRAF (20 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Highly Cited | Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome | Rodriguez-Viciana P , et al. (2006) | No | - |
2 | Highly Cited | Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome | Niihori T , et al. (2006) | No | - |
3 | Support | Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome | Nava C , et al. (2007) | No | Autistic features |
4 | Recent Recommendation | Autism traits in the RASopathies | Adviento B , et al. (2013) | No | Autistic features |
5 | Primary | Behavioral profile in RASopathies | Alfieri P , et al. (2014) | No | Autistic features, ID |
6 | Support | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
7 | Support | Large-scale discovery of novel genetic causes of developmental disorders | Deciphering Developmental Disorders Study (2014) | No | - |
8 | Support | Prevalence and architecture of de novo mutations in developmental disorders | et al. (2017) | No | - |
9 | Support | - | Okuzono S et al. (2019) | No | ASD |
10 | Support | Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population | Monies D , et al. (2019) | No | - |
11 | Recent Recommendation | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | ID |
12 | Support | - | Hiraide T et al. (2021) | Yes | - |
13 | Support | - | Chen JS et al. (2021) | No | ASD |
14 | Support | - | Mahjani B et al. (2021) | Yes | - |
15 | Support | - | Wang Q et al. (2022) | No | - |
16 | Support | - | Hu C et al. (2022) | Yes | - |
17 | Support | - | Zhou X et al. (2022) | Yes | - |
18 | Support | - | Tamam Khalaf et al. (2024) | No | ADHD, epilepsy/seizures |
19 | Support | - | Shenglan Li et al. (2024) | No | - |
20 | Support | - | Ruohao Wu et al. (2024) | Yes | - |
Rare Variants (50)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | translocation | De novo | - | - | 38593811 | Shenglan Li et al. (2024) | |
- | - | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.739T>G | p.Phe247Val | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.770A>G | p.Gln257Arg | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.1591T>A | p.Trp531Arg | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.1595G>A | p.Cys532Tyr | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.1738A>G | p.Asn580Asp | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.1802A>T | p.Lys601Ile | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
n.719+1G>T | p.? | splice_site_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.35C>T | p.Ala12Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1789C>G | p.Leu597Val | missense_variant | Unknown | - | - | 35741772 | Hu C et al. (2022) | |
c.436C>T | p.Arg146Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.622A>G | p.Ile208Val | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.722C>T | p.Thr241Met | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.752G>A | p.Cys251Tyr | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1357C>G | p.Pro453Ala | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1490C>T | p.Ala497Val | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1552G>T | p.Gly518Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1593G>C | p.Trp531Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1595G>A | p.Cys532Tyr | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1673G>A | p.Arg558Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1673G>T | p.Arg558Leu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1820C>T | p.Ser607Phe | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2012G>A | p.Arg671Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1410A>C | p.Ser470%3D | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1713G>T | p.Trp571Cys | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.2296C>T | p.Arg766Cys | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.35C>T | p.Ala12Val | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.722C>T | p.Thr241Met | missense_variant | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.1399T>G | p.Ser467Ala | missense_variant | De novo | - | - | 25363760 | De Rubeis S , et al. (2014) | |
c.1495A>G | p.Lys499Glu | missense_variant | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.1501G>A | p.Glu501Lys | missense_variant | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.2279A>G | p.Tyr760Cys | missense_variant | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.1497A>C | p.Lys499Asn | missense_variant | De novo | - | Simplex | 35266334 | Wang Q et al. (2022) | |
c.1455G>C | p.Leu485Phe | missense_variant | Unknown | - | Unknown | 33753861 | Chen JS et al. (2021) | |
c.1801A>C | p.Lys601Gln | missense_variant | Unknown | - | Unknown | 33753861 | Chen JS et al. (2021) | |
c.1914T>A | p.Ala638%3D | missense_variant | Unknown | - | Unknown | 33753861 | Chen JS et al. (2021) | |
c.722C>T | p.Thr241Met | missense_variant | De novo | - | Simplex | 30414707 | Okuzono S et al. (2019) | |
c.770A>G | p.Gln257Arg | missense_variant | De novo | - | Simplex | 31130284 | Monies D , et al. (2019) | |
c.722C>T | p.Thr241Met | missense_variant | De novo | - | Simplex | 33644862 | Hiraide T et al. (2021) | |
c.1593G>T | p.Trp531Cys | missense_variant | De novo | - | Simplex | 33644862 | Hiraide T et al. (2021) | |
c.1574T>C | p.Leu525Pro | missense_variant | De novo | - | Simplex | 38764027 | Ruohao Wu et al. (2024) | |
c.1406G>A | p.Gly469Glu | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.1574T>C | p.Leu525Pro | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.1593G>C | p.Trp531Cys | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.1783T>C | p.Phe595Leu | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.1801A>C | p.Lys601Gln | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.2126A>G | p.Gln709Arg | missense_variant | Unknown | - | Unknown | 24458522 | Alfieri P , et al. (2014) | |
c.418G>A | p.Cys140Tyr | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.625A>T | p.Lys209Ile | missense_variant | De novo | - | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) |
Common Variants
No common variants reported.
SFARI Gene score
High Confidence, Syndromic
Score Delta: Score remained at 1S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
4/1/2021
Score remained at 1
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
1/1/2021
Score remained at 1
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
10/1/2020
Score remained at 1
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
10/1/2019
Increased from S to 1
New Scoring Scheme
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
Reports Added
[New Scoring Scheme]7/1/2019
Increased from S to S
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
1/1/2016
Increased from S to S
Description
Mutations in the BRAF gene are responsible for cardiofaciocutaneous syndrome (Nava et al., 2007). In two recent reports, patients with cardiofaciocutaneous syndrome mediated by BRAF mutations were found to frequently exhibit autistic features, such as social impairment and internalizing/externalizing problems, as measured by commonly used ASD-related diagnostic tools (Alfieri et al., 2014; Adviento et al., 2014).
Reports Added
[Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with ...2007] [Autism traits in the RASopathies.2013] [Behavioral profile in RASopathies.2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.2006] [Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.2006] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014]Krishnan Probability Score
Score 0.44733567224881
Ranking 12672/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.999978196042
Ranking 515/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.93719177765285
Ranking 13443/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.26871313042008
Ranking 3205/20870 scored genes
[Show Scoring Methodology]
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
ARMCX3 | armadillo repeat containing, X-linked 3 | Human | Protein Binding | 51566 | Q9UH62 |
FKBPL | FK506 binding protein like | Human | Protein Binding | 63943 | Q9UIM3 |
HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | Human | Protein Binding | 3265 | P01112 |
KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | Human | Protein Binding | 3749 | Q03721 |
KIAA0141 | KIAA0141 | Human | Protein Binding | NM_014773 | Q14154 |
LIPF | Gastric triacylglycerol lipase | Human | Protein Binding | 8513 | P07098 |
MAP2K1 | mitogen-activated protein kinase kinase 1 | Human | Protein Binding | 5604 | A4QPA9 |
RAB3GAP1 | RAB3 GTPase activating protein subunit 1 (catalytic) | Human | Protein Binding | 22930 | C9J837 |
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | Human | Protein Binding | 5894 | P04049 |
RPTOR | regulatory associated protein of MTOR, complex 1 | Human | Protein Binding | 57521 | Q8N122 |
YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | Human | Protein Binding | 7529 | P31946 |
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | Human | Protein Binding | 7533 | Q04917 |